Conformis, Inc. (NASDAQ:CFMS)
Industry: Healthcare

Conformis, Inc., a medical technology company, develops, manufactures, and sells joint replacement implants. The company offers customized knee replacement products, including iTotal CR, a cruciate-retaining product; iTotal PS, a posterior cruciate ligament substituting product; iDuo, a customized bicompartmental knee replacement system; and iUni, a customized unicompartmental knee replacement product to treat the medial or lateral compartment of the knee. It also provides Conformis Hip System, a hip replacement product; and iJigs, a customized single-use patient-specific instrumentation. The company markets and sells its products to hospitals and other medical facilities through sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Singapore, Hong Kong, Malaysia, Monaco, Hungary, Spain, and Australia Conformis, Inc. was founded in 2004 and is headquartered in Billerica, Massachusetts.

Current Quote*
Last: $3.130
Change: -0.150
Book: $7.679
Volume: 316,590

As Of: 05/24 13:16 ET
*Quotes delayed by 20min.

BuyIns.Net Alerts for Symbol CFMS

Graphs for CFMS


3 Month Graph


6 Month Graph


1 Year Graph